Fundraising FoxMetaplanet — 2026 Investments
5 investments dated 2026 · listed companies and verified rows first · show all
Hume AI develops infrastructure for emotionally intelligent voice AI, providing datasets, speech models, evaluation frameworks, and human preference pipelines.
AI & Machine LearningData & InfrastructureDeveloper ToolsNew York, US
Alan Cowen(Founder)in
BoardJohn Beadle(Director)Janet Ho(Executive Officer)Andrew Weissman(Director)inJeffrey Kraut(Director)Marc Rubinstein(Director)
Co-investorsAegis VenturesBright Pixel CapitalComcast VenturesLG Technology VenturesUnion Square Ventures (USV)EQT Ventures+3 more
Inherent is an AI research lab, incorporated as a Public Benefit Corporation, developing general-purpose inventive AI systems and "AI Scientist" agents intended to accelerate research and power autonomous labs.
AI & Machine LearningDeep TechEnterprise Software
Co-investorsIndex VenturesRadical VenturesEx/AnteMacroscopic VenturesMythos Ventures Management, LlcPropel Bio Partners
Inherent develops general-purpose AI agents designed to augment scientific research and discovery across disciplines.
AI & Machine LearningDeep Tech
Louis Kirsch(Founder)inTantum Collins(Founder)inEdward Hughes(Founder)Kaloyan Aleksiev(Founder)
Co-investorsMythos Ventures Management, LlcEx/AnteIndex VenturesMacroscopic VenturesPropel Bio PartnersRadical Ventures
JPYC Inc. is a Tokyo-based issuer of a regulated Japanese yen-pegged stablecoin used for payments and settlement.
Noritaka Okabe(Founder)in
Co-investorsAG Capital Co. Ltd.Canal VenturesCircle VenturesGlobal BrainHyperithmi-nest capital+6 more
ParcelBio develops APEXm, a proprietary mRNA platform that enhances protein expression for longer-lasting therapeutic effect compared to conventional mRNA technologies.
AI & Machine LearningBiotechDeep TechHealthtechSan Francisco, US
David Weinberg(CEO)inChris Carlson(Founder)in
BoardMorgan Cheatham(Director)in
Co-investorsY CombinatorBreyer CapitalGeneral CatalystAlumni VenturesLexi VenturesNorth South Ventures+12 more
.png)
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.